Munshi Amit
SEC CIK 1612551 · EDGAR
BoughtSold
Most active insiders at ARQT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Watanabe Todd | See Remarks, Dir | — | $5.32M |
| 2 | Welgus Howard G. | Dir | — | $2.43M |
| 3 | Matsuda Masaru | See Remarks | — | $2.21M |
| 4 | Burnett Patrick | See Remarks | — | $2.02M |
| 5 | Leonard Keith R | Dir | — | $997.1K |
| 6 | Curran Terrie | Dir | — | $984.0K |
| 7 | Edwards Larry Todd | See Remarks | — | $968.4K |
| 8 | Krishnamohan Neha | Dir | — | $939.5K |
| 9 | LIN SUE-JEAN | Dir | — | $898.5K |
| 10 | Gilbert Halley E | Dir | — | $455.5K |
| 13 | Munshi Amit | Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-09 21:21 | 2026-06-05 | ARQT | Arcutis Biotherapeutics, Inc. | Munshi Amit | Dir | A - Grant | $0.00 | +5,778 | 9,799 | +144% | $0 |
| 2026-02-24 | 2026-02-21 | IKT | Inhibikase Therapeutics, Inc. | Munshi Amit | Dir | D - Sale to Iss | $0.00 | -19.1K | 38.2K | -33% | $0 | |
| D | 2025-12-08 | 2025-12-04 | ARQT | Arcutis Biotherapeutics, Inc. | Munshi Amit | Dir | A - Grant | $0.00 | +2,021 | 4,021 | +101% | $0 |
| 2025-08-28 | 2025-02-21 | IKT | Inhibikase Therapeutics, Inc. | Munshi Amit | Dir | A - Grant | $0.00 | +57.3K | 57.3K | New | $0 | |
| DI | 2024-10-23 | 2024-10-21 | IKT | Inhibikase Therapeutics, Inc. | Munshi Amit | Dir | P - Purchase | $1.37 | +365.0K | 365.0K | New | +$500.1K |
| A | 2024-09-06 | 2024-04-22 | ZURA | Zura Bio Ltd | Munshi Amit | Dir | A - Grant | $3.13 | +159.7K | 777.4K | +26% | +$500.0K |
| 2024-04-24 | 2024-04-22 | ZURA | Zura Bio Ltd | Munshi Amit | Dir | P - Purchase | $3.13 | +159.7K | 777.4K | +26% | +$500.0K | |
| 2023-06-05 | 2023-06-05 | ZURA | Zura Bio Ltd | Munshi Amit | Dir | P - Purchase | $4.25 | +117.6K | 617.6K | +24% | +$500.0K |
Purchase Sale Sale after option exercise All abbreviations